[1]王继航 赵施皓 李开亮 田进文 李玉龙 付士辉 沈明志 邓珏琳.远程医疗在高血压病管理中的研究进展[J].心血管病学进展,2019,(9):1199-1201.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.003]
 WANG Jihang,ZHAO Shihao,LI Kailiang,et al.Telemedicine in Hypertension Management[J].Advances in Cardiovascular Diseases,2019,(9):1199-1201.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.003]
点击复制

远程医疗在高血压病管理中的研究进展()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2019年9期
页码:
1199-1201
栏目:
主题综述
出版日期:
2019-12-25

文章信息/Info

Title:
Telemedicine in Hypertension Management
作者:
王继航12 赵施皓2 李开亮3 田进文2 李玉龙1 付士辉2 沈明志12 邓珏琳12
解放军医学院研究生院 国家老年疾病临床医学研究中心,北京 100853;2. 解放军总医院海南医院心血管内科,海南 三亚 572013;3. 解放军总医院第二医学中心心内科,北京 100853)
Author(s):
WANG Jihang12 ZHAO Shihao2 LI Kailiang3 TIAN Jinwen2 LI Yulong1 FU Shihui2 SHEN Mingzhi12 DENG Juelin12
Graduate School of PLA Medical College, National Center for Clinical Medicine of Geriatric Diseases, Beijing 100853; 2. Department of Cardiovascular Disease, Hainan Hospital of PLA General Hospital, Sanya 572013, Hainan, China; 3. Department of Cardiology, Second Medical Center, PLA General Hospital, Beijing 100853,China)
关键词:
高血压远程医疗远程实时血压监测 交互式干预
Keywords:
HypertensionTelemedicineLong-distance real-time blood pressure monitoring Interactive intervention
DOI:
10.16806/j.cnki.issn.1004-3934.2019.09.003
摘要:
高血压是全球范围内重要死亡因素之一。远程医疗模式在疾病诊断和治疗过程中发挥了重要作用。现从高血压流行病学、远程医疗模式、远程医疗在高血压患者管理中的应用、经济成本分析以及在未来研究中需解决的问题及应用前景等方面展开综述。
Abstract:
Hypertension is one of the most important death factors worldwide. Telemedicine plays an important role in the process of disease diagnosis and treatment. This paper reviews the epidemiology of hypertension, the mode of telemedicine, the application of telemedicine in the management of hypertension patients, the analysis of economic components, the problems to be solved in future research and its application prospects.

参考文献/References:

[1]张文博,黄星荷,李静.高血压的流行趋势和治疗进展[J].心血管病学进展,2019,40(3):331-337.
[2]余湘,常静.基于移动医疗的高血压个案管理[J].心血管病学进展,2018,39(6):926-929.
[3]胡盛寿,高润霖,刘力生,等.《中国心血管病报告2018》概要[J].中国循环杂志,2019,34(3):209-220.
[4]Benjamin EJ,Blaha MJ,Chiuve SE,et al.Heart disease and stroke statistics: 2017 update:a report from the American Heart Association[J].Circulation,2017, 135(10): e146-e603.
[5]Arnett DK,Khera A,Blumenthal RS.2019 ACC/AHA guideline on the primary prevention of cardiovascular disease:part 1, lifestyle and behavioral factors[J].JAMA Cardiology,2019,4(10):1043-1044.
[6]de Oliveira-Filho AD, Costa FA, Neves SJ,et al.Pseudoresistant hypertension due to poor medication adherence[J].Int J Cardiol,2014,172(2):e309-e310.
[7]Burnier M, Wuerzner G, Struijker-Boudier H, et al. Measuring,analyzing, and?managing?drug?adherence?in?resistant?hypertension[J].Hypertension,2013,Aug 62(2): 218-225.
[8]黄甫山.存量用户维系需关注用户价值[J].通信企业管理,2018,12(1):50-51.
[9]Sood S, Mbarika V, Jugoo S, et al. What is telemedicine? A collection of 104 peer-reviewed perspectives and theoretical underpinnings[J].Telemed J E Health,2007, 13(5): 573-590.
[10]Thangada ND,Garg N,Pandey A,et al.The emerging role of mobile-health applications in the management of hypertension[J].Curr Cardiol Rep,2018,20(9):1-9.
[11]Wang YL,Zhang L.Application of telephone follow-up health education guidance in patients with hypertension discharged from hospital[J].China Pract Med,2014, 9(17):262-263.
[12]Kim YN,Shin DG,Park S,et al.Randomized clinical trial to assess the effectiveness of remote patient monitoring and physician care in reducing office blood pressure[J].Hypertens Res,2015,38(7):491-497.
[13]Cottrell E,Cox T,O’Connell P,et al.Patient and professional user experiences of simple telehealth for hypertension, medication reminders and smoking cessation: a service evaluation[J].BMJ Open,2015,5(3):e007270.
[14]Albrecht L,Wood PW,Fradette M,et al.Usability and acceptability of a home blood pressure telemonitoring device among community-dwelling senior citizens with hypertension:qualitative study[J].JMIR Aging,2018,1(2):e10975.
[15]Morawski K,Ghazinouri R,Krumme A,et al.Association?of smartphone?application?with?medication?adherence?and?blood?pressure?control:the?medISAFE-BP?randomized?clinical?trial[J].JAMA Intern Med,2018,178(6):802-809.
[16]Heldenbrand S,Dayer L,Renna C,et al.Navigating the flooded adherence app marketplace:rating the quality of edication adherence apps[J].Presented at the American Pharmacist Association Annual Meeting and Exposition, San Diego, CA, 2015.
[17]孟文文,章洁,宋杰,等.基于云平台的远程监测及综合管理对高血压患者知信行的影响[J].护理学杂志,2018,33(1):1-4.
[18]孟文文,麻玉秀,宋杰,等.基于云平台的远程监测及综合管理对门诊高血压患者血压达标率的影响[J].解放军医学院学报,2017,38(10):977-980+997.
[19]Margolis KL,Asche SE,Dehmer SP,et al.Long-term?outcomes?of the?effects?of?home?blood?pressure?telemonitoring?and?pharmacist?management?on?blood?pressure?among?adults?with?uncontrolled?hypertension:?follow-up?of?cluster?randomized?clinical?trial[J].JAMA Netw Open,2018,1(5):e181617.
[20]Stoddart A,Hanley J,Wild S,et al.Telemonitoring-based service redesign for the management of uncontrolled hypertension (HITS):cost and cost-effectiveness analysis of a randomised controlled trial[J].BMJ Open,2013,3(5):e002681.
[21]Kaambwa B,Bryan S,Jowett S,et al.Telemonitoring and self‐management in the control of hypertension (TASMINH2): a cost‐effectiveness analysis[J].Eur J Prev Cardiol,2014,21(12):1517-1530.
[22]Upatising B,Wood DL,Kremers WK,et al.Cost comparison between home telemonitoring and usual care of older adults: a randomized trial (Tele-ERA) [J].Telemed J E Health, 2015,21(1):3-8.
[23]Padwal RS,So H,Wood PW,et al.Cost‐effectiveness of home blood pressure telemonitoring and case management in the secondary prevention of cerebrovascular disease in Canada[J].J Clin Hypertens (Greenwich),2019,21(2):159-168.?
[24]Yang XH,Zhang WX,Shuai W,et al.The clinical diagnosis rate of hypertension in the subjects with newly-diagnosed hypertension identified by epidemiological study[J].Chin J Hypertens,2018,26(11):1026-1029.

相似文献/References:

[1]孙刚,黄冠华,综述.高血压合并心力衰竭的治疗策略[J].心血管病学进展,2016,(2):201.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.027]
 SUN Gang,HUANG Guanhua.Treatment Strategy of Hypertension with Heart Failure[J].Advances in Cardiovascular Diseases,2016,(9):201.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.027]
[2]范贵娟,综述,徐瑞,等.盐敏感性高血压的研究进展[J].心血管病学进展,2016,(4):364.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.010]
 FAN Guijuan,XU Rui.Research Progress of Salt Sensitive Hypertension[J].Advances in Cardiovascular Diseases,2016,(9):364.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.010]
[3]陈源源.钙通道阻滞剂在降压治疗中的应用[J].心血管病学进展,2015,(6):662.[doi:10.3969/j.issn.1004-3934.2015.06.002]
 CHEN Yuanyuan.Application of Calcium Channel Blockers in Hypertension Treatment[J].Advances in Cardiovascular Diseases,2015,(9):662.[doi:10.3969/j.issn.1004-3934.2015.06.002]
[4]张瑞 毛露 孙硕 Dirk Hermann 陈艾东.内皮素-1干预成为高血压治疗新靶点的展望[J].心血管病学进展,2019,(7):969.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.000]
 ZHANG Rui MAO LuSUN ShuoDIRK Hermann CHEN Aidong.The Prospect of Endothelin-1 Intervention as A New Target for the Treatment of Hypertension[J].Advances in Cardiovascular Diseases,2019,(9):969.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.000]
[5]张毅,柳志红.动态血压监测在高血压中的应用现状与问题[J].心血管病学进展,2019,(6):848.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.003]
 ZHANG Yi,LIU Zhihong.Current status and nsolved Pproblems of Ambulatory Blood Pressure Monitoring for the Management of Hypertension[J].Advances in Cardiovascular Diseases,2019,(9):848.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.003]
[6]黄秋瑾 胡蓉.高血压合并糖尿病患者血压控制率和控制目标的探讨[J].心血管病学进展,2019,(7):973.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.002]
 HUANG QiujinHU Rong.Discussion on Blood Pressure Control Rate and Control Target in Patients with Hypertension Complicated with Diabetes[J].Advances in Cardiovascular Diseases,2019,(9):973.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.002]
[7]张旭明 王曦.高血压对认知功能的影响[J].心血管病学进展,2019,(7):977.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.003]
 ZHANG Xuming,WANG Xi.The Relationship Between Hypertension and Cognitive Function[J].Advances in Cardiovascular Diseases,2019,(9):977.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.003]
[8]凌梦军 陈明凌梦军.阻塞性睡眠呼吸暂停低通气综合征与高血压关系的研究进展[J].心血管病学进展,2019,(5):722.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.015]
[9]李波 郭毅 田进文 邓珏琳.高血压合并2型糖尿病的治疗进展[J].心血管病学进展,2019,(9):1196.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.002]
 LI Bo,GUO Yi,TIAN Jinwen,et al.Therapy in Hypertensive Patients with Type 2 Diabetes Mellitus[J].Advances in Cardiovascular Diseases,2019,(9):1196.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.002]
[10]付士辉李玉龙骆雷鸣沈明志田进文邓珏琳.高血压基础研究现状与进展[J].心血管病学进展,2019,(9):1202.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.004]
 FU ShihuiLI YulongLUO LeimingSHEN MingzhiTIAN JinwenDENG Juelin.Status and Progress of Basic Researches about Hypertension[J].Advances in Cardiovascular Diseases,2019,(9):1202.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.004]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金(81500202)国家老年疾病临床医学研究中心2018年度开放课题(NCRCG-PLAGH-2018014)海南省重点研发(ZDYF2019188,ZDYF2018118)收稿日期:2019-10-14
更新日期/Last Update: 2020-02-06